Retrobulbar Block and/or General Anesthesia for Orbital Ball Implants After Enucleation Surgery.
pprb
1 other identifier
observational
300
1 country
2
Brief Summary
Retrobulbar block is used to provide perioperative analgesia and anesthesia for orbital ball implants after enucleation surgery in the investigator's hospital. Retrobulbar block alone can provide quicker recovery, decreased time to discharge, opioid sparing, reduced costs. However, patients undergoing orbital ball implants after enucleation surgery with retrobulbar block alone suffered more preoperative and intraoperative anxiety,postoperative pain, and postoperative nausea and vomiting. General anesthesia alone is administered to patients undergoing orbital ball implants after enucleation surgery and opioids are used in adjunct with general anesthesia to suppress pain and hemodynamic stress associated with surgical trauma. GA only associated with more systemic opioids, short-term cognitive impairment, somnolence, and postoperative nausea and vomiting that can increase patient morbidity and delay discharge. Opioids, however, can result in adverse effects such as nausea and vomiting, pruritus, sedation. As a result of this growing demand of efficient and effective anesthesia management for orbital ball implants after enucleation surgery is becoming increasingly important. Numerous studies have reported benefits of an retrobulbar block for orbital ball implants after enucleation surgery, including quicker recovery and decreased time to discharge, decreased pain scores, opioid sparing, reduced costs, less intraoperative hemodynamic variability, improved patient satisfaction, and, in some cases, reduced GA- and/or opioid-related side effects. A recent systematic review examining all modes of postoperative pain management following orbital ball implants after enucleation surgery concluded that retrobulbar block are superior to all other forms of postoperative pain control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2019
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2019
CompletedFirst Posted
Study publicly available on registry
April 24, 2019
CompletedStudy Start
First participant enrolled
June 28, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 18, 2020
CompletedDecember 19, 2020
December 1, 2020
6 months
February 26, 2019
December 16, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
postoperative pain upon arrival at and discharge from the postanesthesia care unit
Visual Analogue Scale score(0-10, no pain - worse) of postoperative pain,
through study completion: an average of 24 hour
analgesic consumption
Dose of analgesic consumption
through study completion: an average of 24 hours
rescue analgesia
Rate of rescue analgesia
through study completion, an average of 24 hours
Secondary Outcomes (1)
Postoperative nausea and vomiting
through study completion, an average of 24 hours
Eligibility Criteria
Patients were included if they underwent orbital ball implants after enucleation surgery by one ophthalmologist surgeon specializing in oculoplastic and orbital surgery at our centre above 18 years old
You may qualify if:
- Patients were included if they underwent orbital ball implants after enucleation surgery by one ophthalmologist surgeon specializing in oculoplastic and orbital surgery at our centre.
You may not qualify if:
- Patients were excluded if they underwent other concurrent surgical procedures, or were under 18 yr of age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
叶伟娣
Hangzhou, China
Weidi Ye
Hanzhou, China
Study Officials
- STUDY CHAIR
Zhiying Wu, Doctor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2019
First Posted
April 24, 2019
Study Start
June 28, 2019
Primary Completion
December 28, 2019
Study Completion
July 18, 2020
Last Updated
December 19, 2020
Record last verified: 2020-12